SHOrt Course Radiation and TASOX (TAS102 Plus Oxaliplatin) Chemotherapy in Operable Rectal Cancer
Clinical trial NCT04417699 · COMPLETED
Trial details
- NCT number
- NCT04417699
- Sponsor
- Providence Health & Services
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-05
- Primary completion
- 2023-12-14
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.